Tag: Diabetes: Management
SGLT-2 Inhibitors Tied to Lower Risk for Autoimmune Rheumatic Diseases in Adults With T2D
SGLT-2 inhibitors linked lower risk for autoimmune rheumatic diseases compared with sulfonylureas
AI-Enabled Bundle of Sensors, Coaching Aids Type 2 Diabetes Outcomes
Significant improvements seen in glycemic control, weight loss, and de-escalation of glucose-lowering pharmacotherapy versus usual care
Participation in National Diabetes Prevention Program Is Cost-Saving
Medical costs reduced over two years for privately insured adults with prediabetes participating in the program
Position Statement Addresses Optimal Management of Diabetes
Tools available to help health care providers include guided communication styles, clinical screening tools for psychosocial conditions
Health Coaching With Family Support Aids Patient Activation With Diabetes
However, no significant improvements seen for diabetes-specific cardiac risk or glycemic control
‘Teach-Back’ Communication Strategy Aids Diabetes Outcomes
Patients who use teach-back have fewer diabetes-related complications, hospitalizations, health expenditures
CVD Risk Higher in T2DM Even With Optimal Risk Factor Management
Those with T2DM with optimal risk factor control have greater risk for cardiovascular disease events versus those without T2DM
Sitagliptin May Cut Mortality in T2DM Patients With COVID-19
Manufacturer Prices for Insulin Substantially Higher in the U.S.
